Concepedia

Darren W. Davis

DW

Statistics

Publications

67

Citations

7.3K

H-Index

43

Active since

1995

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Michigan State University

National Cancer Institute

The University of Texas Health Science Center at Houston

Incell Corporation (United States)

Darren W. Davis is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1995–2023

67

Publications

67

Civil Liberties vs. Security: Public Opinion in the Context of the Terrorist Attacks on America

Darren W. Davis, Brian D. Silver · American Journal of Political Science · 2003 · 723 citations

, , +12

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

Christiane J. Bruns, Matthew T. Harbison, Darren W. Davis et al. · PubMed · 2000 · 422 citations

, , +17

ApoStream™, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood

Vishal Gupta, Insiya Jafferji, Miguel Garza et al. · Biomicrofluidics · 2012 · 379 citations · Full text

, , +17

Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis.

Raymond M. Shaheen, Darren W. Davis, Wenbiao Liu et al. · PubMed · 1999 · 337 citations

, , +17

Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

Roy S. Herbst, Kenneth R. Hess, Hai T. Tran et al. · Journal of Clinical Oncology · 2002 · 277 citations

, , +14

1–5 of 67